MariMed Inc. (MRMD) stock

MRMDOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 1/30

$0.06−0.00 (-3.39%)

Close on Oct 19, 2026Market cap $22.78MP/E –Yield –

MariMed statistics

43 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings: –
Last ex-dividend date: No dividends
Fundamentals through: Jun 30, 2026
Share price as of: –

Share statisticsIndustry

Shares Outstanding: 403M; 58M
Shares Change (YoY): 3.30%; 10.8%
Shares Change (QoQ): 0.57%; 0.50%
Float: 359M; 49M
Shares Held by Insiders: 10.9%; 11.7%
Shares Held by Institutions: 0.16%; 56.4%

MarginsIndustry

Gross Margin: 35.6%; 53.1%
Operating Margin: -1.45%; -38.7%
Pretax Margin: -6.21%; -11.6%
Profit Margin: -9.13%; -31.6%
EBITDA Margin: 3.84%; -27.7%
FCF Margin: 4.89%; -9.56%

Returns on capitalIndustry

Return on Assets (ROA): -7.45%; -40.6%
Return on Capital Employed (ROCE): -1.79%; -37.9%

Financial positionIndustry

Current Ratio: 0.92; 3.30
Quick Ratio: 0.28; 2.39
Interest Coverage: -0.30; -6.35

GrowthIndustry

Revenue Growth (YoY): 4.37%; 6.82%
Revenue Growth (3Y CAGR): 6.05%; 2.25%
Revenue Growth (5Y CAGR): 25.7%; 6.41%

EfficiencyIndustry

Asset Turnover: 0.82; 0.40
Inventory Turnover: 2.79; 2.73
Revenue Per Employee: $177.49K; $429.29K
Profits Per Employee: -$16.20K; -$689.41K
Employee Count: 923; 74

Income statement (TTM)Industry

Revenue: $163.82M; $66.37M
Gross Profit: $58.37M; $120.78M
Operating Income: -$2.38M; -$21.37M
Pretax Income: -$10.18M; -$12.95M
Net Income: -$14.95M; -$22.35M
EBITDA: $6.29M; -$17.21M
EPS (Diluted): -$0.04; -$0.76

Balance sheetIndustry

Cash & Short-Term Investments: $8.44M; $68.68M
Net Cash (Debt): $8.44M; $17.76M
Net Cash Per Share: $0.02; $0.80
Working Capital: -$5.32M; $79.99M

Cash flow (TTM)Industry

Operating Cash Flow: $9.27M; -$12.38M
Capital Expenditures: -$1.26M; -$1.00M
Free Cash Flow: $8.01M; -$18.21M
FCF Per Share: $0.02; -$0.42

Taxes and interestIndustry

Interest Expense: $7.96M; $2.90M
Income Tax: $4.74M; $73.00K

Scores and fair valueIndustry

Piotroski F-Score: 3; 4

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Oct 19, 2026. The S&P 500 is measured by the SPY fund.

Period	MRMD	S&P 500	Difference	MRMD per year	S&P 500 per year
1 month	-22.0%	+0.6%	−22.7 pts
3 months	-13.4%	+3.4%	−16.7 pts
Year to date	-39.3%	+13.3%	−52.6 pts
1 year	-62.7%	+16.6%	−79.3 pts
3 years	-85.4%	+86.4%	−171.8 pts	-47.3%	+23.1%
5 years	-93.0%	+81.9%	−174.9 pts	-41.3%	+12.7%
10 years	-54.4%	+318.9%	−373.3 pts	-7.6%	+15.4%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

0M MRMD shares were sold short on Oct 30, 2026, up 1748.6% from the previous report. At recent volumes it would take 1.0 days to buy them back.

Settlement date	Shares short	Change	Avg. daily volume	Days to cover
Oct 30, 2026	18,486	+1748.6%	761,607	1.0
Oct 15, 2026	1,000	0.0%	999,138	1.0
Sep 30, 2026	1,000	-97.8%	1,661,239	1.0
Sep 15, 2026	44,669	+112.7%	769,089	1.0
Aug 31, 2026	20,999	-4.4%	1,828,278	1.0
Aug 14, 2026	21,955	+124.2%	473,231	1.0
Jul 31, 2026	9,792	+151.5%	433,915	1.0
Jul 15, 2026	3,893	+108.6%	548,629	1.0
Jun 30, 2026	1,866	-88.4%	668,174	1.0
Jun 15, 2026	16,030	-75.0%	1,406,144	1.0
May 29, 2026	64,138	+1827.8%	1,254,952	1.0
May 15, 2026	3,327	-84.0%	1,290,557	1.0